| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/22/1997 | WO1997017992A1 Improved formulation for administration of steroid compounds |
| 05/22/1997 | WO1997017978A1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 05/22/1997 | WO1997017951A1 Stabilized thyroid hormone preparations and methods of making same |
| 05/22/1997 | WO1997017947A1 Directly compressible high load acetaminophen formulations |
| 05/22/1997 | WO1996041813A3 Functionalized polymers for site-specific attachment |
| 05/22/1997 | WO1996041606A3 Improved pharmaceutical compositions for gene therapy |
| 05/22/1997 | WO1996040262A3 Process for preparing encapsulated water soluble beta-carotene |
| 05/22/1997 | CA2237398A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 05/22/1997 | CA2235707A1 Stabilized thyroid hormone preparations and methods of making same |
| 05/21/1997 | EP0774009A1 Process for preparing viruses and viral vectors |
| 05/21/1997 | EP0774006A2 Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells |
| 05/21/1997 | EP0774005A1 Surface expression of enzyme in gene directed prodrug therapy |
| 05/21/1997 | EP0773975A1 Conducting electroactive biomaterials |
| 05/21/1997 | EP0773955A1 New thrombin inhibitors, their preparation and use |
| 05/21/1997 | EP0773951A1 Dinucleoside-5',5'-pyrophosphates |
| 05/21/1997 | EP0773950A1 Linked peptide nucleic acids |
| 05/21/1997 | EP0773796A1 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
| 05/21/1997 | EP0773791A1 Drug delivery composition for the nasal administration of antiviral agents |
| 05/21/1997 | EP0773781A1 Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| 05/21/1997 | EP0773780A1 Controlled release aqueous emulsion |
| 05/21/1997 | EP0773779A1 Highly bioadhesive and mucoadhesive compositions for the treatmenof epithelia and mucous membranes |
| 05/21/1997 | EP0773719A1 Compositions for targeting materials to cells containing androgen receptors |
| 05/21/1997 | EP0713389A4 Hydrolyzed gelatin as a flavor enhancer in a chewable tablet |
| 05/21/1997 | EP0527821B1 Oxidation resistant thrombomodulin analogs |
| 05/21/1997 | CN1150391A Dendrimeric compounds |
| 05/21/1997 | CN1150019A Pharmaceutical combination preparation comprising ketoprofen |
| 05/20/1997 | US5631336 Endcapped hydroxyalkoxy or alkoxycarbonylalkoxy groups |
| 05/20/1997 | US5631329 Process for producing hyper-comb-branched polymers |
| 05/20/1997 | US5631322 Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces |
| 05/20/1997 | US5631301 Topical antibiotic composition providing optimal moisture environment |
| 05/20/1997 | US5631297 Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same |
| 05/20/1997 | US5631296 Drugs containing S(+)-ibuprofen |
| 05/20/1997 | US5631287 Storage-stable prostaglandin compositions |
| 05/20/1997 | US5631244 mono(6-amino-6-deoxy)cyclodextrin derivatives substituted in the 6-position by an α-amino acid residue, process for their preparation and their uses |
| 05/20/1997 | US5631243 Protective lubricants for eye surgery which can easily be removed, in mixture with mucopolysaccharides |
| 05/20/1997 | US5631241 Wound healing agents of high molecular weight for eyes as antiinflammatory agents |
| 05/20/1997 | US5631229 Method for inactivating gonadotrophs |
| 05/20/1997 | US5631225 Pharmaceutical formulation |
| 05/20/1997 | US5631154 Polypeptides, genetic engineering and assembly of defective viral particles |
| 05/20/1997 | US5631023 Method for making freeze dried drug dosage forms |
| 05/20/1997 | US5631022 Picosulfate dosage form |
| 05/20/1997 | US5631019 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 05/20/1997 | US5631018 Lipid-polymer conjugates and liposomes |
| 05/20/1997 | US5631015 Sustained release of drugs with bioabsorbable lactone polymer |
| 05/20/1997 | US5630996 Two-step pretargeting methods using improved biotin-active agent conjugates |
| 05/18/1997 | CA2163163A1 Low-irritation anesthetic and antiseptic mouth rinse |
| 05/15/1997 | WO1997017386A1 Water-soluble or water-dispersible polyurethanes with terminal acid groups, the production and the use thereof |
| 05/15/1997 | WO1997017087A1 Stabilizing formulation for ngf |
| 05/15/1997 | WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 05/15/1997 | WO1997017065A1 Cellulose acetate phthalate enteric coating compositions |
| 05/15/1997 | WO1997017064A1 Stable freeze-dried pharmaceutical formulation |
| 05/15/1997 | WO1997017061A1 Therapeutic preparation for the transdermal administration of active substances |
| 05/15/1997 | WO1997017038A1 Tissue re-surfacing with hydrogel-cell compositions |
| 05/15/1997 | DE3690626C2 Medicinal compsn. for trans-dermal use |
| 05/15/1997 | DE19541679A1 Gene transfer systems containing nuclear localisation sequences and or magnetisable microparticles, |
| 05/14/1997 | EP0773441A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 05/14/1997 | EP0773295A2 DNA-based vaccination of fish by immersion |
| 05/14/1997 | EP0773229A1 Cyclodextrin derivatives and their use, especially in cosmetics |
| 05/14/1997 | EP0773034A1 Biodegradable in-situ forming implants |
| 05/14/1997 | EP0773028A1 Percutaneously absorbable preparation |
| 05/14/1997 | EP0773025A1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process |
| 05/14/1997 | EP0773018A1 Cosmetic and/or pharmaceutical emulsions |
| 05/14/1997 | EP0773017A1 Cosmetic and/or pharmaceutical emulsions |
| 05/14/1997 | EP0772776A1 Superparamagnetic particles, process for their production and their use |
| 05/14/1997 | EP0772773A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
| 05/14/1997 | EP0772641A1 Melt-processible poly(ester urethane) and a process for the preparation thereof |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/14/1997 | EP0772452A1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix |
| 05/14/1997 | EP0772436A1 Incorporation of biologically active molecules into bioactive glasses |
| 05/14/1997 | EP0772435A1 Controlled release of metal cation-stabilized interferon |
| 05/14/1997 | EP0772434A1 Method of preparing natural-oil-containing emulsions and microcapsules and its uses |
| 05/14/1997 | EP0536255B1 Ophthalmic suspensions |
| 05/14/1997 | EP0510132B1 Polymeric carriers for release of covalently linked agents |
| 05/14/1997 | CN1149834A Cyclosporin containing composition and process for preparation |
| 05/14/1997 | CN1149831A Controlled-release dosage forms of azithromycin |
| 05/14/1997 | CN1149829A Polymer coated tablet comprising amoxycillin and clavulanate |
| 05/14/1997 | CN1034872C Polymeric materials made from destructurized starch and at least one synthetic thermoplastic polymeric material |
| 05/13/1997 | US5629384 Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces |
| 05/13/1997 | US5629316 Stabilized solid pharmaceutical preparation and method of producing the same |
| 05/13/1997 | US5629299 Hydrolytic stabilizer for unstable organic ions |
| 05/13/1997 | US5629276 Composition of alkyl pyrrolidone for solubilizing antibacterials |
| 05/13/1997 | US5629198 Porphyrin derivative |
| 05/13/1997 | US5629184 To cell cytoplasm, antisense therapy |
| 05/13/1997 | US5629161 Use of human papillomavirus gene derived peptides for diagnosis |
| 05/13/1997 | US5629090 Starch hydrolysates as sequesterers |
| 05/13/1997 | US5629020 Delivery of sensitive agents such as bioactive peptides |
| 05/13/1997 | US5629019 Formulations with hydrophobic permeation enhancers |
| 05/13/1997 | US5629018 Composition for controlled release of an active substance and method for the preparation of such a composition |
| 05/13/1997 | US5629017 Programmed release oral solid pharmaceutical dosage form |
| 05/13/1997 | US5629015 Composition for combating ageing acting simultaneously on the surface layers and deep layers of the skin and use thereof |
| 05/13/1997 | US5629011 Absorption promoters for derivatives of opioid analgesics |
| 05/13/1997 | US5629006 Skin disinfecting formulations |
| 05/13/1997 | US5629003 Rapidly disintegrating sheet-like presentations of multiple dosage units |
| 05/13/1997 | US5629001 Oral administration of therapeutic proteins for treatment of infectious disease |
| 05/13/1997 | US5628993 Interferon and polyglycerol diester of stearic acid or palmitic acid |
| 05/13/1997 | US5628979 Reagent for tumor imaging and therapy |
| 05/13/1997 | US5628930 Stabilization of fluorocarbon emulsions |
| 05/13/1997 | CA2039247C Multiple encapsulated flavor delivery system and method of preparation |
| 05/09/1997 | WO1997016474A1 Targeted magnetically labeled molecular marker systems for the nmr imaging |